Introduction To Clinical Research And Ethical Considerations Practice Test

Strong data privacy in research hinges on a layered approach that reduces risk at several points. First, remove direct identifiers, so obvious personal details like names or exact IDs aren’t attached to the data. Then, minimize re-identifiability by evaluating what indirect or quasi-identifiers could combine with other data to reidentify someone. Governance comes next: a data-use agreement lays out who can access the data, for what purposes, and how results can be shared. Limiting access means only authorized individuals can work with the data, supported by authentication, role-based controls, and audit logs. Finally, store and transmit the data securely with encryption so that even if data are intercepted or accessed without authorization, they remain unreadable. This combination reduces privacy risk, supports ethical research, and aligns with regulatory expectations. Shaping the practice this way is preferable because relying on encryption alone while keeping a direct-identifier file for quick reference still creates a vulnerable linkage map if the key or file is compromised. Sharing raw data without agreements bypasses essential governance and oversight. Relying on de-identified data without any governance ignores ongoing risk management and accountability, since de-identification can fail or be reverse-engineered and access controls are still needed to monitor and enforce permissible uses.